Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)

Background
The Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional) grant is issued by the National Institutes of Health (NIH), specifically through its components such as the National Cancer Institute (NCI), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), and the National Institute on Minority Health and Health Disparities (NIMHD).

The purpose of this funding opportunity is to support policy research projects that examine new or adapted policies related to tobacco, alcohol, and cannabis in the U.S., with a focus on how these policies affect usage and secondhand exposure among populations experiencing health disparities. The overarching goal is to promote health equity and cancer prevention by addressing substance use issues.

Grant Details
The funded projects will involve authentic engagement with community organizations aimed at promoting equity in cancer prevention. Specific research topics include:

1) Comprehensive smoke-free environment policies;
2) Policies reducing appeal through advertising restrictions;
3) Pricing interventions like minimum unit pricing;
4) Regulations on sales including age restrictions;
5) Treatment coverage policies for substance use disorders.

Projects must measure tobacco, alcohol, and cannabis use or secondhand exposure before and after policy implementation. Collaboration with community organizations is mandatory, ensuring their involvement from conception to dissemination of findings.

Eligibility Requirements
Eligible applicants include higher education institutions, nonprofits, for-profit organizations, local/state governments, tribal governments, and faith-based organizations. Institutions that are historically underrepresented in NIH funding are encouraged to apply. Applicants must demonstrate a meaningful partnership with a community organization.

Period of Performance
The project period must not exceed five years. Applications can be submitted starting January 5, 2025, with various due dates for application submissions throughout the year until January 8, 2028.

Grant Value
Award budgets are limited to $500,000 in direct costs per year. The total value of the grant may vary based on NIH appropriations and the number of meritorious applications received.

Place of Performance
The grant will be performed within the United States.